Join to View Full Profile
920 Stanton L Young BlvdOklahoma City, OK 73104
Phone+1 405-271-5963
Fax+1 405-271-3064
Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2013 - 2016- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2010 - 2013
Kottayam Medical CollegeClass of 2004
Certifications & Licensure
OK State Medical License 2012 - 2025
Clinical Trials
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
- Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer Start of enrollment: 2021 May 07
Publications & Presentations
PubMed
- Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study.Sarbajit Mukherjee, Yu Fujiwara, Christos Fountzilas, Harsha Pattnaik, Sarah Chatley
Cancer Medicine. 2025-04-01 - 7 citationsProspective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.William A Hall, Jiahe Li, Y Nancy You, Marc J Gollub, Joseph R Grajo
Journal of Clinical Oncology. 2023-10-10 - 10 citationsThe evolving role of radiation in pancreatic cancer.Midhun Malla, Fatemeh Fekrmandi, Nadia Malik, Hassan Hatoum, Sagila George
Frontiers in Oncology. 2022-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
